Letermovir and maribavir for pan-resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy.
Jana K DickterJustine Abella RossJasmine M ZainBernard R TegtmeierBrian V LeeSanjeet S DadwalPublished in: Journal of clinical pharmacy and therapeutics (2022)
Combination therapy, used for other infections to prevent cross-resistant, may apply for CMVi.
Keyphrases